Insights

  • Home
  • Insights
  • Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

Share

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

March 09, 2018 Commentary

The Stock Exchange of Hong Kong Limited (the "Exchange") published the Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors on February 23, 2018 (the "Consultation Paper"), and proposed to introduce a new chapter ("Chapter 18A") to the Main Board Listing Rules (the "Listing Rules") to implement the proposal of allowing the listing of pre-revenue/pre-profit biotech companies on the Main Board of the Exchange (the "Main Board").

The Consultation Paper clarifies uncertainties in the previous proposal (particularly on determining whether a product has been developed beyond the concept stage) and enables biotech companies seeking listing in Hong Kong to effectively assess if they could meet the relevant requirements.

This Jones Day White Paper reviews key points in the Consultation Paper.

Contributors
You May Also Be Interested In

November 22, 2024 Podcast

JONES DAY TALKS®: The Five Pillars of Protection for Later Stage VC Investors

November 20, 2024 Firm Hosted

Considerations For the Development and Licensing of Patent Portfolios

November 13, 2024 Commentary

Landmark Climate Change Case Overturned: The Hague Court of Appeals Overturns Ruling Ordering Shell to Reduce CO2 Emissions

November 07, 2024 Handout

Energy Transition in the Construction and Infrastructure Industry

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.